Drug Delivery Devices Market Size, Share & Industry Analysis, By Route of Administration (Injectable, Nasal, Topical & Transdermal, Oral and Others), By Type (Conventional and Advanced), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Drug Delivery Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Drug Delivery Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Drug Delivery Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Drug Delivery Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Drug Delivery Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Drug Delivery Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

""Continuous Investments in Development of Drug Delivery Devices and New Product Launches by Key Players Will Intensify Competition""
The global market is fragmented in nature with a large number of key players operating worldwide. These companies are making efforts to deliver patient-friendly, therapeutically effective, and smart devices. Key players such as BD, 3M, West Pharmaceutical Services Inc., Emergent BioSolutions Inc., Insulet Corporation, Consort Medical plc, as well as other prominent players play huge role in bringing up novel and technology-enhanced drug delivery devices in the market. Merging and acquisitions between the local and multinational players has contributed to the healthy market competition.

Furthermore, delivering and innovation into advanced drug delivery devices such as nanotechnology-based devices is the upcoming trend adopted by the market players.

LIST OF KEY PLAYERS PROFILED IN THE REPORT:

  
BD
  
Emergent Biosolutions Inc.
  
Consort Medical plc
  
Aptar Pharma
  
West Pharmaceutical Services Inc.
  
Insulet Corporation
  
Nemera
  
SHL Medical AG.
  
Pfizer Inc.
  
Other Prominent Players

REPORT COVERAGE

  
An Infographic Representation of Drug Delivery Devices Market
  
View Full Infographic

To get information on various segments, share your queries with us

The drug delivery devices market report highlights the leading regions across the world that offers a better understanding of the market for the user. Furthermore, the report provides insights into the latest industry trends, new product launches, pipeline analysis and key industry developments such as mergers, acquisition, and partnerships. It further throws light on some of the growth-stimulating factors and restraints, helping the reader to gain in-depth knowledge about the market.

Report Scope and Segmentation

Segmentation

By Route of Administration

  
Injectable
  
Nasal
  
Topical & Transdermal
  
Oral
  
Others

By Type

  
Conventional
  
Advanced

By Distribution Channel

  
Hospital Pharmacies
  
Retail Pharmacies
  
Online Pharmacies

By Geography

  
North America (the U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and the Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)

 

KEY INDUSTRY DEVELOPMENTS:

October 2019: Aptar Pharma announced the of its patented Unidos liquid system Tosymra for treatment of migraine in the U.S.

August 2019: Nemera announced the acquisition of Insight Product Development to strengthen its capabilities as an early-stage development company and provide drug delivery devices services to consumers in North America.